Babar Ghias - Jul 7, 2025 Form 3 Insider Report for BIOCRYST PHARMACEUTICALS INC (BCRX)

Role
CFO & Head of Corp Development
Signature
/s/ Alane P. Barnes, by power of attorney
Stock symbol
BCRX
Transactions as of
Jul 7, 2025
Transactions value $
$0
Form type
3
Date filed
7/11/2025, 04:35 PM
Next filing
Jul 28, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Ghias Babar CFO & Head of Corp Development 4505 EMPEROR BLVD., SUITE 200, DURHAM /s/ Alane P. Barnes, by power of attorney 2025-07-11 0002076862

No securities are beneficially owned.

Remarks:

Exhibit List - Exhibit 24 - Power of Attorney